Back to Search Start Over

Myocardial protection by glucose-insulin-potassium in acute coronary syndrome patients undergoing urgent multivessel off-pump coronary artery bypass surgery.

Authors :
Shim JK
Yang SY
Yoo YC
Yoo KJ
Kwak YL
Shim, J-K
Yang, S-Y
Yoo, Y-C
Yoo, K-J
Kwak, Y-L
Source :
BJA: The British Journal of Anaesthesia. Jan2013, Vol. 110 Issue 1, p47-53. 7p.
Publication Year :
2013

Abstract

<bold>Background: </bold>The aim of this randomized and controlled trial was to investigate the effect of a glucose-insulin-potassium (GIK) solution on myocardial protection in acute coronary syndrome (ACS) patients undergoing urgent multivessel off-pump coronary artery bypass (OPCAB) surgery.<bold>Methods: </bold>Sixty-six patients were randomly allocated either to receive 0.3 ml kg(-1) h(-2) GIK solution (potassium 80 mEq and regular insulin 325 IU in 500 ml of 50% glucose) or equivalent volume of normal saline (control) upon anaesthetic induction until 6 h after reperfusion. The primary endpoints were to compare the concentrations of creatine kinase-MB (CK-MB) and troponin-T between the groups after reperfusion. The secondary endpoints were to compare the incidences of postoperative troponin-T >0.8 ng ml(-1) and myocardial infarction (MI) between the groups.<bold>Results: </bold>Highest CK-MB [8.7 (4.4) vs 13.1 (7.9) ng ml(-1), P=0.006] and troponin-T [0.20 (0.13-0.49) vs 0.48 (0.18-0.91) ng ml(-1), P<0.0001] values after reperfusion were significantly lower in the GIK group compared with the control group. The area under the curve of serially measured troponin-T was also significantly smaller in the GIK group compared with the control group [0.83 (0.43-1.81) vs 0.46 (0.31-1.00), P=0.036]. Significantly fewer patients in the GIK group showed troponin-T >0.8 ng ml(-1) after reperfusion compared with the control group (3 vs 11, P=0.033). The incidence of postoperative MI was similar between the groups.<bold>Conclusions: </bold>GIK administration in ACS patients undergoing urgent multivessel OPCAB significantly attenuated the degree of ensuing myocardial injury without complications related to glycaemic control. Clinical Trial Registry. URL: http://clinicaltrials.gov/ct2/show/NCT01384656?term=GIK+AND+OPCAB&rank=1. Unique identification number NCT01384656. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00070912
Volume :
110
Issue :
1
Database :
Academic Search Index
Journal :
BJA: The British Journal of Anaesthesia
Publication Type :
Academic Journal
Accession number :
104402054
Full Text :
https://doi.org/10.1093/bja/aes324